HIGHLIGHTS
- who: Riccardo Giampieri from the (UNIVERSITY) have published the article: Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis, in the Journal: (JOURNAL) of 05/04/2017
- what: The study was performed in accordance with the protocol, all experimental protocols were approved by the Ethical Committee of the Azienda Ospedaliera Universitaria of Ancona, Italy, written informed consent was obtained for all patients enrolled into the analysis and methods were carried out in accordance with the approved guidelines.
- how: In the TRIBUTE (Toxicity during Regorafenib Induction and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.